the community site for and by developmental biologists
This page lists events that are of interest to the global community of developmental biologists: conferences, meetings, training courses, workshops.
To add a conference to this calendar, please register for an account. Once your account has been approved you will receive instructions on how to add an event.
Epigenetic Mechanisms Across Scales: From Molecules to Environment and Evolution
Application Deadline: April 1, 2019
Instructors: Karen Adelman, Aaron Johnson, Marc Mendillo
This course integrates omics approaches to understand the principle of chromatin operation and its biological relevance. We will analyse the composition and variation of chromatin components, and the “epigenetic landscape” at key time points following the induction of cellular differentiation.
Translational control focus of attention extends to many fields, including developmental biology, neurobiology, cell physiology, disease, synthetic and systems biology, among others. Besides messenger RNA translation, the conference features advances in epitranscriptomics and non-coding RNAs that influence the translation process.
Exploring the developmental origins of health and disease
Audience: scientists working on foetal programming, ecologists and evolutionary biologists interested in the effects of the parental environment on offspring.
Discussion topics will include:
Abstract submission deadline: May 13, 2019
This workshop belongs to the series “Current Trends in Biomedicine”, organized by the Universidad Internacional de Andalucía (UNIA) at the “Sede Antonio Machado” of Baeza (Andalusia, Spain).
More information and application at https://www.unia.es/biomedicine
This year’s conference will cover a broad spectrum of epigenomic discoveries, opportunities, and also challenges, in human normal biology and in disease and discuss and discuss epigenomic approaches in common human diseases.
The symposium will focus in particular on how metabolites and metabolic networks impact gene regulation, on recently discovered roles of metabolites in disease and how this open novel therapeutic avenues.
This meeting aims to present the most recent advances in the mechanistic understanding of DNA metabolic processes at the single-molecule level, using both in vivo and in vitro approaches.
Bringing together leading figures in nuclear receptor research, to discuss emerging roles and their implications for health and disease in an intimate meeting that will generate meaningful idea exchange to further shape this influential field.
Talks will cover a broad range of topics, including chromosome organisation, long-range interactions, chromatin assembly, stem cell regulation/differentiation, RNA-based mechanisms, transcription regulation, DNA methylation and hydroxymethylation.
This meeting will bring together academic and industry scientists and clinicians working on developing and implementing gene therapy and cell-based therapy for a wide variety of conditions.
This meeting will bring together experts and pioneers in studying neuroepigenetics and epitranscriptomics to provide an up-to-date and comprehensive picture of epigenetic and epitranscriptomic mechanisms in neural development, reprogramming and cell identity, plasticity, neuronal function and dysfunction.
This unique conference brings together multiple international research communities around common topics, including developmental genetics. Share your work with the C. elegans, Drosophila, mammalian, yeast, Xenopus, zebrafish, population, evolutionary, and quantitative genetics communities, along with those researching humans and plants.
The conference will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. Sessions include; Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.
This meeting will appeal to Molecular/Cell Biologists/Geneticists & Biochemists interested in genome stability. Researchers interested in the molecular basis of cancer, neurodegenerative diseases and ageing and those with an interest in high throughput genetic and pharmacological screening methods.
